SAR-218034

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSAR-218034
Drug Alias NameSAR-218034
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/hydrogen exchanger 3 inhibitors
TargetsSodium/hydrogen exchanger 3
Therapy Area/IndicationsSleep Apnea, Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsSleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A